For acquired mechanical prosthetic heart valve (PHV) obstruction and suspicion on thrombosis, recently updated European Society of Cardiology guidelines advocate the confirmation of thrombus by transthoracic echocardiography, transesophageal echocardiography (TEE), and fluoroscopy. However, no evidence-based diagnostic algorithm is available for correct thrombus detection, although this is clinically important as fibrinolysis is contraindicated in non-thrombotic obstruction (isolated pannus). Here, we performed a review of the literature in order to propose a diagnostic algorithm.
Introduction
Recently updated European Society of Cardiology (ESC) guidelines advocate the confirmation of thrombus formation by transthoracic echocardiography (TTE), transesophageal echocardiography (TEE), and fluoroscopy in acquired mechanical prosthetic heart valve (PHV) obstruction in order to justify treatment strategies such as fibrinolysis and heparine infusion. 1 After exclusion of patient prosthesis mismatch (PPM) by comparison of the TTE result with the initial post-operative TTE, the most probable cause of acquired mechanical PHV obstruction is thrombosis or pannus formation with an incidence of 0.4 -6.0% per year, depending on the valve type and position. 2 -4 One of the treatment options of obstructive thrombosis is fibrinolysis, whereas in obstructive pannus this is contraindicated. In clinical practice, the differentiation of obstructive thrombus from isolated pannus remains challenging though very important when fibrinolysis is considered. Obstructive PHV thrombosis has an association with inadequate anti-coagulation, short duration between PHV implantation and symptoms, and urgent requirement for treatment. 4 -6 However, these clinical parameters are not reliable enough for differentiation in the individual patient. Furthermore, pre-test probabilities (before imaging) for obstructive pannus, thrombus, or both, reported in a total of 412 cases, are 6-63%, 24-81%, and 0-44% and therefore non-discriminative. 2, 4, 7, 8 For this reason, patients with acquired obstruction of their PHV require non-invasive imaging for the differentiation of thrombus from pannus, which is crucial to choose the correct treatment strategy and correctly to implement the guidelines in daily practise. 1 However, the diagnostic role of non-invasive imaging techniques for the determination of the cause of acquired mechanical PHV obstruction has not been systematically reviewed and determined until now. The purpose of this systematic review was to determine and compare the diagnostic role of TTE, TEE, fluoroscopy, and multidetector-row computed tomography (MDCT) for the detection of the exact cause of acquired mechanical PHV obstruction, based on the currently available literature. Biological and nonobstructive PHV's were excluded because the diagnostic dilemmas mostly concern obstructed mechanical PHV's. Based on the results, we will suggest an evidence-based imaging strategy for the differentiation of obstructive thrombus from pannus.
Methods

Literature search
A systematic electronic search was performed in the Pubmed and Embase databases for original publications published until 5 November 2012. Language was restricted to English articles and publications from before 1985 were excluded because of inferior echocardiographic imaging quality and non-representative old mechanical valve types. Key search terms included the non-invasive imaging modalities (TTE, TEE, fluoroscopy, and MDCT) and synonyms for PHVs. The detailed search string is shown in Supplementary data online, Appendix I. For all included full-text papers, cross-referencing was performed.
Selection of publications
After removal of duplicates, the titles and abstracts were independently screened by two reviewers (W.T. and J.H.). Articles were included if: (i) studies reported on one of the following non-invasive index tests (TTE, TEE, fluoroscopy, or MDCT); (ii) studies provided data on features of mechanical PHV obstruction defined as: (a) leaflet restriction detected by fluoroscopy [opening angles usually + two standard deviations (+2SD) of the mean of normal opening angles] 3, 9 ; (b) Doppler measured peak gradients greater than/effective orifice area (EOA) smaller than usually +2 SD of the mean values obtained from the patients own first post-operative TTE or from the reference group with normally functioning valves of the same type, size, and position 10 ; (iii) imaging results were verified against one of the following reference standards (surgical inspection/autopsy or clinical follow-up/successful fibrinolysis) and retrospective thrombolysis studies that used inclusion criteria for already identified obstructive PHV thrombosis patients were excluded because the inherent selection bias. Case reports were excluded for the same reason. Full-text publications of the included articles were obtained and assessed by two reviewers (W.T. and J.H.) independently. In a consensus meeting, both reviewers extensively discussed the full-text publications and data extraction.
PHV selection
From the included articles biological PHVs, PHV's without the predefined reference standard, non-obstructive PHV's, and PPM were excluded.
Quality assessment
Information on patient population, study enrolment, non-invasive imaging modalities, and reference standard were collected. Studies were systematically assessed for quality based on the validated Quality Assessment of Diagnostic Accuracy Studies (QUADAS) II checklist.
11
This checklist assesses the risk of bias and clinical applicability of studies based on different domains: (i) patient selection, (ii) index test, (iii) flow and timing, and (iv) reference standard. 11 If studies had concerns in all domains they were of poor methodologically quality and if there were no concerns of good quality. Studies with and without domains of concern were of moderate methodologically quality.
Data analysis
The primary purpose of this review was to determine and compare the diagnostic role of non-invasive imaging modalities for diagnosing the exact cause of PHV obstruction. Based on these results, an imaging strategy will be suggested for differentiation of thrombotic PHV obstruction vs. non-thrombotic obstruction.
Results
Search results
The systematic electronic search yielded a total of 4271 Pubmed and 8287 Embase publications. After screening of all titles and abstracts, 89 full-text versions of studies that matched the inclusion criteria were obtained. Seventy-seven studies were excluded because of different reasons ( Figure 1 ). Cross-referencing of all included full-text articles resulted in three additional articles. Many studies reported on PHV dysfunction, but only a few fulfilled the inclusion criteria. In total, only 15 studies were included in this review.
Result of systematic electronic search Table 1 demonstrates all included studies (n ¼ 15) that reported on the diagnostic cause of acquired mechanical PHV obstruction. The inclusion period occurred completely or partially before 1990 in 20% of studies. Data were prospectively collected in 47% of studies, and the assessment of the index test was blinded in 40% of studies. The interval between index test and reference standard was reported in 27% of studies and in 47% of all included studies all patients received a reliable reference standard (surgery/successful fibrinolysis). According to the QUADAS II and aforementioned data on patient selection, flow/timing, assessment of the index test, and the reference standard, there are concerns regarding the risk of bias and applicability in a vast majority of studies. None of studies were of good methodological quality, two had a poor methodological quality, and the rest of studies moderate. These 15 studies included a total of 671 PHV's with at least one non-invasive examination (TTE/TEE/fluoroscopy, or MDCT) for the evaluation of PHV obstruction ( Table 2) . Four hundred and thirty-three of 671 (65%) PHV's were excluded from the analysis for the following reasons: (i) PHV bioprosthesis (n ¼ 64), (ii) nonobstructive mechanical PHV's (n ¼ 78), (iii) PPM (n ¼ 19), and (iv) the absence of the pre-defined reference standard (n ¼ 272). In total, 238 obstructed mechanical PHV's were included. The distribution of pannus, thrombus, combination of thrombus/pannus, or others were: 75 of 212 (35%), 129 of 212 (61%), 5 of 212(2%), and 3 of 212(1%), respectively. In this distribution, 26 PHV's described by Lin et al. 6 were not included, because the two different causes of obstruction namely: thrombus and the combination of pannus/ thrombus were reported together as one group.
Fluoroscopy
From 11 studies reporting on obstructed PHV's and the diagnostic role of fluoroscopy, 146 PHV's could be included ( Table 2) .
Restricted leaflet opening
Restricted leaflet opening was defined as persistent diminished motion of at least one of the leaflets usually with a calculated opening angle (+2 SD) different from the values obtained in a reference group of patients with normally functioning valves of the same type, size, and position. 3 Fluoroscopy was performed in 146 PHV's, aortic (AVR, n ¼ 69), mitral (MVR, n ¼ 73), and tricuspid (TVR, n ¼ 4). Restriction was observed by fluoroscopy in 139 of 146 (95%) mechanical valves, caused by either pannus alone (n ¼ 38), thrombus alone (n ¼ 101), thrombus + pannus (n ¼ 4), or others (n ¼ 3). All PHV's obstructed by thrombus (105 of 105, 100%) showed leaflet restriction by fluoroscopy ( Table 3) . Montorsi et al. 12 evaluated 54 obstructive PHV's with and without leaflet restriction. In this study, patients received surgery or fibrinolysis only when TEE detected masses. In 28 PHV's (22 mitral and 6 aortic), a mass was detected and confirmed to be thrombus after surgery or fibrinolysis. However, in this study, a serious selection bias in favour of the detection of thrombus has been introduced as the 26 other patients with mainly aortic (23 of 26) PHV's were treated conservatively because no mass was found by TEE. Muratori et al.
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reported on 111 patients with and without leaflet restriction Differentiation between pannus and thrombus by non-invasive imaging detected by fluoroscopy. Fluoroscopy was superior in imaging of leaflet motion compared with echocardiography, particularly in aortic PHV's. Forty-one of the 111 patients had leaflet restriction detected by fluoroscopy. In this study, a serious selection bias was also introduced because only patients with leaflet restriction (n ¼ 41) underwent surgery/fibrinolysis. This revealed thrombus as the underlying cause in all patients except one which was caused by pannus. 13 Moreover, Aoyagi et al. 14 described 20 patients with acquired mechanical PHV obstruction and a significant leaflet restriction at fluoroscopy. Sixteen of 20 patients had thrombus as the cause for PHV obstruction; however, the others had surgically confirmed pannus (4 of 20). Of note, two of the four pannus cases received unjust and non-successful thrombolytic therapy before surgery.
14 In addition, another study of Montorsi et al. described 17 patients with leaflet restriction on fluoroscopy, suspected for obstructive thrombus. They all received fibrinolysis, however, in 5 of 17 (29%) this was unsuccessful as pannus was the underlying cause. 15 Although the aforementioned studies 12 -15 have a serious selection bias, they
show that leaflet restriction detected by fluoroscopy was primarily caused by thrombus, and to a lesser extent by pannus. Six other studies support this observation.
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Absent leaflet restriction Seven of 146 (5%) PHV's showed normal leaflet opening on fluoroscopy, despite significantly acquired elevated Doppler gradients ( Table 3) . Thrombus was found in none of these PHV's, pannus (4 of 7), or LVOT obstruction (3 of 7) was the underlying cause.
Two-dimensional echocardiography
Six studies reported on the diagnostic role of echocardiography in acquired mechanical PHV obstruction ( Fluoroscopy was performed in 146 PHV's, aortic (n ¼ 69), mitral (n ¼ 73), and tricuspid (n ¼ 4). Specification of the diagnosis obstructive thrombosis/pannus for PHV position was not possible as some studies did not report these data. Data extracted from: Vogel et al., 19 Aoyagi et al., 14 Aoyagi et al., 17 Montorsi et al., 12 Girard et al., 16 Montorsi et al., 15 Teshima et al., 24 Muratori et al., 13 Symersky et al., 18 Tsai et al., 21 and Ueda et al. Data extracted from: Habib et al., 22 Barbetseas et al., 5 Girard et al., 16 Montorsi et al.
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AVR, mechanical prosthetic heart valve in aortic position; MVR, mechanical prosthetic heart valve in mitral position.
published that are beyond the scope of this article. Only one retrospective case series study is published on the additional value of 3D TTE, compared with 2D TTE, in five PHV's obstructed by thrombus and two by pannus. 23 In this study performed by Singh et al., surgery or successful fibrinolysis was the reference standard. In four of seven (57%) patients, 2D TTE missed masses, whereas 3D TTE missed only two of the seven (29%) masses. The missed masses with 3D-TTE were the two pannus cases. This small study suggests possible benefit of 3D echocardiography in detecting thrombi; however, the small sample size prohibits definite conclusions. 23 
Multidetector Computed Tomography
Four studies reported on the diagnostic value of MDCT. Teshima et al. 24 reported 13 aortic PHV patients, in which MDCT detected subprosthetic tissue located on the ventricular side of the aortic PHV ring with attenuation values equal to those of the interventricular septum. However, only two patients were operated on and had surgically confirmed pannus. Symersky et al. 18 included patients with acquired PHV obstruction of unknown cause, in order to investigate the additional value of MDCT for the detection of the underlying cause of obstruction. Eight mechanical PHVs were re-operated on, and five patients had surgically proven thrombus and/or pannus. MDCT had detected all these masses. The three other patients had obstruction due to a suture knot (n ¼ 1) or subvalvular membrane (n ¼ 2), also correctly identified by MDCT. 18 Ueda et al. recently published on a group of nine patients with acquired mechanical aortic PHV obstruction confirmed by systolic restriction at fluoroscopy. In that patients who underwent echocardiography no masses were detected. All patients underwent MDCT, which detected subvalvular masses with an anatomical configuration matching pannus, confirmed by surgery in all patients. 20 In contrast to
Teshima et al., this study reported Houndsfield units of the subvalvular masses to be significantly higher than the ventricular septum. 24 
Discussion
This review of the literature shows that differentiation between pannus and thrombus as the cause of acquired mechanical PHV obstruction remains challenging. However, it is clinically very important to exclude isolated pannus when fibrinolysis is considered, in order to prevent exposure to serious complications with a reported incidence varying between 17 and 25% of the cases. 25, 26 Despite a limited number and moderate methodological quality of studies, non-invasive imaging plays a key role in treatment decisions (surgery or fibrinolysis) in patients with obstructive PHV's. According to the recently published ESC guidelines on valvular heart disease, confirmation of thrombus in patients with obstructive PHV's is required, because only PHV thrombosis can be treated by fibrinolysis. 1 However, the guidelines provide no diagnostic strategy for thrombus confirmation and concomitant differentiation from pannus. Based on available literature and our opinion, we suggest an imaging strategy for this clinical problem ( Figure 2) . After exclusion of non-obstructive PHV's and PPM by comparing with first post-operative TTE, we propose to perform fluoroscopy by cineradiography 12 -19 or MDCT as the next diagnostic step. 3, 18, 27, 28 Fluoroscopy in patients with acquired mechanical PHV obstruction is valuable, although an important limitation of fluoroscopy is the orientation of the PHV. For certain orientations such as an anatomically placed bileaflet mitral PHV and aortic PHV parallel to the ventricular septum, it may not be possible to obtain a good perpendicular view of the leaflets. 9 In these cases, MDCT may be an alternative. If there is no leaflet restriction in patients with obstructed PHV's (high gradients/diminished EOA), thrombus is highly unlikely as the cause of obstruction and pannus is the most likely underlying mechanism ( Table 3) . Pannus is able to cause obstruction without restriction of leaflet opening, because overgrowth of fibrous tissue is located upstream of the PHV ring ( Figure 3, Case 1) . 29 For further confirmation of pannus or exclusion of very rare other causes of obstruction such as PHV dislocation or re-growth of subvalvular membranes, additional MDCT and/or TEE may be considered (Figure 2) . When leaflet restriction is detected by fluoroscopy, both thrombus and pannus can be the cause of PHV obstruction (Tables 3 and 5 and Figure 3 , Case 2/3). Furthermore, pannus can be superposed by thrombosis and therefore, co-exists. In this situation, we advise to perform a TEE for mass detection. If a mass is not present or not visible, thrombosis cannot be confirmed and surgery is the only defendable treatment strategy in symptomatic patients. Fibrinolysis studies already showed that TEE detected masses in all thrombosis cases; however, mass detection by TEE was the main inclusion criterion in these retrospective studies. 26, 30, 31 These studies were not included in the present systematic review, because there was no diagnostic dilemma regarding PHV obstruction, namely PHV thrombosis was already diagnosed. However, the present study also showed that obstruction by thrombosis is almost always accompanied by mass detection by TEE ( Table 4) . Although this conclusion may be confounded as the thrombotic group with mass detection by TEE concerns mostly mitral PHV's (Table 4) , in which imaging is less hampered by acoustic shadowing compared with other PHV's. Nevertheless, in case of the detection of a mass .2.0 cm (especially if attached to the leaflet and of low echo density), the treatment flowchart of the ESC guidelines for confirmed thrombosis can be followed and fibrinolysis is one of the treatment options 1, 5 ( Figure 2) . Considering the lower sensitivity of thrombus detection by TEE in obstructed aortic PHV's, in case of absent (or small) mass detection, an additional MDCT can be performed for thrombus detection in order to avoid surgery in patients eligible for fibrinolysis. Although TTE is an excellent diagnostic tool for the determination of the severity of obstruction, in most of the cases it is not able to detect masses interfering with PHV opening. TEE can detect masses obstructing PHV's in mitral position, but is less suitable for PHV's in aortic position due to acoustic shadowing, particularly if the mass is localized at the anterior side of the aortic PHV. 16, 20 This conclusion may be confounded as the incidence of pannus (smaller masses) in the included aortic PHV's is much higher than included mitral PHV's ( Table 4 ). This observation, however, reflects our daily clinical experience as it is known that mitral PHV's are more prone to thrombosis and aortic PHV more to obstructive pannus. In theory, 3D TEE might increase diagnostic accuracy, but studies are still lacking and also 3D TEE is hampered by acoustic shadowing by the PHV. Only one reliable study on (2D TEE) differentiation between pannus and thrombus in 20 obstructed PHV's has been reported. 5 All the echocardiographic evidence for pannus and thrombus differentiation is based on this small study, which reported that large mass length and low echo density are associated with Differentiation between pannus and thrombus by non-invasive imaging thrombus ( Table 5) . However, these parameters have not been confirmed by other studies. As aortic PHV's MDCT seems to be a promising imaging modality to differentiate pannus formation based on anatomical configuration of the perivalvular masses. mechanical obstruction by leaflet restriction ( Figure 3 and Table 5 , Case 3). Theoretically also mass differentiation (thrombus vs. pannus) should be possible by determining the Houndsfield units, though no evidence is available.
Limitations
First, the majority of the included studies dealt with thrombosis patients with PHV's in mitral position and pannus patients with mainly aortic PHV's. Secondly, only surgically explored or thrombolysed patients were included. This has resulted in a major selection bias. Thirdly, obstructed PHV's with leaflet obstruction at fluoroscopy and mass detection at TEE possibly underwent surgery/thrombolysis more easily. This also resulted in a selection bias in favour of thrombosis. Fourthly, methodological quality of the studies was generally moderate. This could have influenced our conclusions. Fifthly, data on novel imaging techniques (3D TEE and MDCT) are Differentiation between pannus and thrombus by non-invasive imaging preliminary. Sixthly, studies concern mainly left-sided PHV's, therefore no conclusions can be drawn for right-sided PHV's.
Conclusion
This review shows that studies on acquired mechanical PHV obstruction are scarce and have a varying (moderate) methodological quality. Based on this review and our opinion, in acquired mechanical PHV obstruction without leaflet restriction at fluoroscopy and/or absent TEE mass, thrombosis cannot be confirmed and fibrinolysis is not advised. In contrast, the presence of leaflet restriction and/or TEE mass detection can be caused by either thrombus and/or pannus masses. Evidence for reliable echocardiographic thrombus and pannus mass differentiation is limited. In situation of a diagnostic impasse, MDCT might be a promising complementary imaging modality for correct thrombus/pannus differentiation. Well-designed, large prospective, cross-sectional studies are needed to determine the additional value of MDCT and 3D TEE for determination of the cause of acquired PHV obstruction.
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